Evidence map›Paper›PMID 15784566›Full record

ArticleInfection and immunity2005

Function of neisserial outer membrane phospholipase a in autolysis and assessment of its vaccine potential.

Martine P Bos, Boris Tefsen, Pierre Voet, Vincent Weynants, Jos P M van Putten, Jan Tommassen

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. The role of extracellular DNA inJournal of bacteriology · 2026
    Review
  3. Review
  4. Article
  5. Clinical microbiology reviews · 2024
    Review
  6. Mutation ofJournal of bacteriology · 2023
    Article
  7. Mutation ofbioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. Regulated Expression ofInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Deletion of D-Lactate Dehydrogenase A inFrontiers in microbiology · 2019
    Article
  12. Review
  13. Regulation ofFEBS open bio · 2017
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Martine P BosDepartment of Molecular Microbiology and Institute for Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. m.p.bos@bio.uu.nl
Boris Tefsen
Pierre Voet
Vincent Weynants
Jos P M van Putten
Jan Tommassen
GlaxoSmithKline (Belgium) · BEUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outer membrane phospholipase A (OMPLA) is an outer membrane-localized enzyme, present in many gram-negative bacterial species. It is implicated in the virulence of several pathogens. Here, we investigated the presence, function, and vaccine potential of OMPLA in the human pathogen Neisseria meningitidis. Immunoblot analysis showed the presence of OMPLA in 28 out of 33 meningococcal strains investigated. The OMPLA-negative strains all contained a pldA gene, but these alleles contained premature stop codons. All six Neisseria gonorrhoeae strains tested, but only two out of seven commensal neisserial strains investigated, expressed OMPLA, showing that OMPLA is expressed by, but not limited to, many pathogenic neisserial strains. The function of OMPLA was investigated by assessing the phenotypes of isogenic strains, expressing no OMPLA, expressing wild-type levels of OMPLA, or overexpressing OMPLA. OMPLA exhibited phospholipase activity against endogenous phospholipids. Furthermore, OMPLA was characterized as an autolysin that acted under specific conditions, such as prolonged growth of the bacteria. The vaccine potential of the protein was investigated by immunizing mice with in vitro refolded, recombinant OMPLA. High levels of antibody titers were obtained, but the murine sera were neither bactericidal nor protective. Also, convalescent patients and vaccinee sera did not contain detectable levels of anti-OMPLA antibodies, indicating that OMPLA may not be sufficiently immunogenic to be included in a meningococcal vaccine.

Indexed as

Amino Acid SequenceBacterial Outer Membrane ProteinsBacterial VaccinesBacteriolysisBase SequenceMolecular Sequence DataNeisseria gonorrhoeaeNeisseria meningitidisPhospholipases ABacterial Outer Membrane ProteinsBacterial VaccinesPhospholipases A

Identifiers

PMID15784566
PMCPMC1087465
OpenAlexW2114200482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.